How COVID-19 could harm the brain
In a new study, researchers reviewed neurological symptoms in patients with COVID-19.
They found that altered mental status and stroke are the most common neurological...
This drug could speed up recovery in people with COVID-19
In a new study, researchers found that treatment with antivirals such as interferons may strongly improve virus clearance and reduce levels of inflammatory proteins...
Countries with female leaders suffer six times fewer COVID-19 deaths
The COVID-19 crisis points to female leadership as a marker for healthier and more equal societies that are more receptive to political agendas placing...
This new test may revolutionize diagnosis of prostate cancer
Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require...
Green tea compound may help treat this deadly infectious disease
Southeast Asia accounts for 41% of the world’s tuberculosis cases, with 4 million new cases every year.
While there are already drugs that target mycobacterium...
Wearing face masks at home may help reduce COVID-19 spread among family members
In a new study, researchers found that wearing face masks at home might help ward off the spread of COVID-19 infection among family members...
Any exercise could lower heart disease risk in overweight people
In a new study, researchers found that for obese or overweight adults, any amount of exercise might lower the risk of developing heart disease...
Scientists find COVID-19 path from animals to humans
In a new study, researchers examined the origin of SARS-CoV-2, the virus that has caused the COVID-19 pandemic.
They found that it was especially well-suited...
Five-day use of this drug could benefit people with severe COVID-19
In a new study, researchers found that there is no big difference between a five- and 10-day use of remdesivir for people with severe...
Inherited high cholesterol may be common in people with heart disease
An inherited disorder that causes high cholesterol early in life appears to affect about 25 million people worldwide, but it is especially common among...